Myomo (MYO) CMO sells shares outside 10b5-1 trading plan

Rhea-AI Filing Summary

MYOMO, INC. (MYO) reported that Chief Medical Officer Harry Kovelman sold common stock in an open-market transaction. On 2026-08-20, he sold 17,250 shares at a weighted average price of $1.7331 per share, with individual sale prices ranging from $1.72 to $1.75. Following this sale, he directly holds 105,983 shares of MYO common stock. The transaction was not reported as being made under a Rule 10b5-1 trading plan.

Insider Trade Summary

Net Seller: 17,250 shares

Net Sell 1 txn

Insider Kovelman Harry

Role Chief Medical Officer

Sold 17,250 shs ($30K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	17,250	$1.7331	$30K

Holdings After Transaction: Common Stock — 105,983 shares (Direct)

Footnotes (1)

1. F1. Represents weighted average sales price. Shares sold in open market transactions in multiple lots at prices ranging from $1.72 to $1.75 per share. Reporting party agrees to provide details of the transactions to the SEC upon request.

Key Figures

Shares sold: 17,250 shares of Common Stock Weighted average sales price: $1.7331 per share Sale price range: $1.72 to $1.75 per share +1 more

4 metrics

Shares sold 17,250 shares of Common Stock Sale by Chief Medical Officer on 2026-08-20

Weighted average sales price $1.7331 per share Open-market sale on 2026-08-20, with multiple trade lots

Sale price range $1.72 to $1.75 per share Price range for multiple open-market lots in the reported sale

Shares held after transaction 105,983 shares Direct holdings of Harry Kovelman following the sale

Key Terms

weighted average sales price, open market transactions, Common Stock

3 terms

weighted average sales price financial

"Represents weighted average sales price. Shares sold in open market"

open market transactions market

"Shares sold in open market transactions in multiple lots at prices"

Open market transactions are the buying and selling of a company’s shares or other securities conducted on public exchanges or through the wider market rather than through private deals or negotiated placements. They matter to investors because these trades change supply and demand in real time—like shoppers affecting a store’s inventory—and so can move prices, signal management or investor sentiment, affect liquidity, and alter ownership stakes that influence future returns and risk.

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

What insider transaction did MYO report for Harry Kovelman?

MYOMO, INC. reported that Chief Medical Officer Harry Kovelman sold 17,250 shares of MYO common stock on 2026-08-20 in an open-market transaction at a weighted average price of $1.7331 per share, with trade prices between $1.72 and $1.75.

At what price did the MYO insider shares sell in this Form 4 filing?

The reported sale by MYOMO, INC.’s Chief Medical Officer used a weighted average sales price of $1.7331 per share. According to the footnote, the shares were sold in multiple open-market lots at prices ranging from $1.72 to $1.75 per share.

How many MYO shares does Harry Kovelman own after the reported sale?

After the 17,250-share sale reported on this Form 4, Chief Medical Officer Harry Kovelman directly owns 105,983 shares of MYOMO, INC. common stock. This figure reflects his holdings immediately following the reported transaction.

Was the MYO insider sale made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not marked, and the footnote describes the trades only as open market transactions. There is no indication that this sale was executed under a Rule 10b5-1 trading plan.

What does the footnote say about the MYO insider’s sale prices?

The footnote explains that the reported $1.7331 price is a weighted average sales price. Shares were sold in multiple open-market lots at prices ranging from $1.72 to $1.75 per share, and detailed trade information is available to the SEC upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/21/2026 - 06:18 PM Accepted by SEC EDGAR 08/21/2026 - 06:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kovelman Harry

(Last) (First) (Middle)

C/O MYOMO, INC.

45 BLUE SKY DR., SUITE 101

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MYOMO, INC. [ MYO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2026		S		17,250	D	$1.7331(1)	105,983	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents weighted average sales price. Shares sold in open market transactions in multiple lots at prices ranging from $1.72 to $1.75 per share. Reporting party agrees to provide details of the transactions to the SEC upon request.

	/s/ David A. Henry, Attorney-in-Fact	08/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)